Literature DB >> 23670193

Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1.

Chihiro Yamazaki1, Masanaka Sugiyama, Tomokazu Ohta, Hiroaki Hemmi, Eri Hamada, Izumi Sasaki, Yuri Fukuda, Takahiro Yano, Mikako Nobuoka, Takeshi Hirashima, Akihiko Iizuka, Katsuaki Sato, Takashi Tanaka, Katsuaki Hoshino, Tsuneyasu Kaisho.   

Abstract

Dendritic cells (DCs) consist of various subsets that play crucial roles in linking innate and adaptive immunity. In the murine spleen, CD8α(+) DCs exhibit a propensity to ingest dying/dead cells, produce proinflammatory cytokines, and cross-present Ags to generate CD8(+) T cell responses. To track and ablate CD8α(+) DCs in vivo, we generated XCR1-venus and XCR1-DTRvenus mice, in which genes for a fluorescent protein, venus, and a fusion protein consisting of diphtheria toxin receptor and venus were knocked into the gene locus of a chemokine receptor, XCR1, which is highly expressed in CD8α(+) DCs. In both mice, venus(+) cells were detected in the majority of CD8α(+) DCs, but they were not detected in any other cells, including splenic macrophages. Venus(+)CD8α(+) DCs were superior to venus(-)CD8α(+) DCs with regard to their cytokine-producing ability in response to TLR stimuli. In other tissues, venus(+) cells were found primarily in lymph node (LN)-resident CD8α(+), LN migratory and peripheral CD103(+) DCs, which are closely related to splenic CD8α(+) DCs, although some thymic CD8α(-)CD11b(-) and LN CD103(-)CD11b(-) DCs were also venus(+). In response to dsRNAs, diphtheria toxin-treated XCR1-DTR mice showed impaired CD8(+) T cell responses, with retained cytokine and augmented CD4(+) T cell responses. Furthermore, Listeria monocytogenes infection and anti-L. monocytogenes CD8(+) T cell responses were defective in diphtheria toxin-treated XCR1-DTRvenus mice. Thus, XCR1-expressing DCs were required for dsRNA- or bacteria-induced CD8(+) T cell responses. XCR1-venus and XCR1-DTRvenus mice should be useful for elucidating the functions and behavior of XCR1-expressing DCs, including CD8α(+) and CD103(+) DCs, in lymphoid and peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23670193     DOI: 10.4049/jimmunol.1202798

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Cross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103- and XCR1+CD103+ dendritic cells.

Authors:  Ben Wylie; Elke Seppanen; Kun Xiao; Rachael Zemek; Damien Zanker; Sandro Prato; Bree Foley; Prue H Hart; Richard A Kroczek; Weisan Chen; Jason Waithman
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

2.  Development of a Novel CD4+ TCR Transgenic Line That Reveals a Dominant Role for CD8+ Dendritic Cells and CD40 Signaling in the Generation of Helper and CTL Responses to Blood-Stage Malaria.

Authors:  Daniel Fernandez-Ruiz; Lei Shong Lau; Nazanin Ghazanfari; Claerwen M Jones; Wei Yi Ng; Gayle M Davey; Dorothee Berthold; Lauren Holz; Yu Kato; Matthias H Enders; Ganchimeg Bayarsaikhan; Sanne H Hendriks; Lianne I M Lansink; Jessica A Engel; Megan S F Soon; Kylie R James; Anton Cozijnsen; Vanessa Mollard; Alessandro D Uboldi; Christopher J Tonkin; Tania F de Koning-Ward; Paul R Gilson; Tsuneyasu Kaisho; Ashraful Haque; Brendan S Crabb; Francis R Carbone; Geoffrey I McFadden; William R Heath
Journal:  J Immunol       Date:  2017-10-30       Impact factor: 5.422

Review 3.  Studying interactions between dendritic cells and T cells in vivo.

Authors:  Aleksey Chudnovskiy; Giulia Pasqual; Gabriel D Victora
Journal:  Curr Opin Immunol       Date:  2019-03-15       Impact factor: 7.486

4.  Mesenteric lymph node CD11b- CD103+ PD-L1High dendritic cells highly induce regulatory T cells.

Authors:  Aya Shiokawa; Ryutaro Kotaki; Tomohiro Takano; Haruyo Nakajima-Adachi; Satoshi Hachimura
Journal:  Immunology       Date:  2017-06-01       Impact factor: 7.397

5.  Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy.

Authors:  Jing Liu; Elisa A Rozeman; Jake S O'Donnell; Stacey Allen; Lorenzo Fanchi; Mark J Smyth; Christian U Blank; Michele W L Teng
Journal:  Oncoimmunology       Date:  2018-11-22       Impact factor: 8.110

6.  Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node.

Authors:  Masahiro Kitano; Chihiro Yamazaki; Akiko Takumi; Takashi Ikeno; Hiroaki Hemmi; Noriko Takahashi; Kanako Shimizu; Scott E Fraser; Katsuaki Hoshino; Tsuneyasu Kaisho; Takaharu Okada
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-11       Impact factor: 11.205

7.  Trigger-happy resident memory CD4+ T cells inhabit the human lungs.

Authors:  A E Oja; B Piet; C Helbig; R Stark; D van der Zwan; H Blaauwgeers; E B M Remmerswaal; D Amsen; R E Jonkers; P D Moerland; M A Nolte; R A W van Lier; P Hombrink
Journal:  Mucosal Immunol       Date:  2017-11-15       Impact factor: 7.313

8.  Robust Anti-viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions.

Authors:  Sarah Eickhoff; Anna Brewitz; Michael Y Gerner; Frederick Klauschen; Karl Komander; Hiroaki Hemmi; Natalio Garbi; Tsuneyasu Kaisho; Ronald Nathan Germain; Wolfgang Kastenmüller
Journal:  Cell       Date:  2015-08-18       Impact factor: 41.582

Review 9.  Kidney dendritic cells: fundamental biology and functional roles in health and disease.

Authors:  Christian Kurts; Florent Ginhoux; Ulf Panzer
Journal:  Nat Rev Nephrol       Date:  2020-05-05       Impact factor: 28.314

10.  Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.

Authors:  Se Jin Im; Masao Hashimoto; Michael Y Gerner; Junghwa Lee; Haydn T Kissick; Matheus C Burger; Qiang Shan; J Scott Hale; Judong Lee; Tahseen H Nasti; Arlene H Sharpe; Gordon J Freeman; Ronald N Germain; Helder I Nakaya; Hai-Hui Xue; Rafi Ahmed
Journal:  Nature       Date:  2016-08-02       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.